Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-06-15 5:00 pm Unchanged | 13D | Science 37 Holdings Inc. SNCE | Redmile Group LLC | 19,808,234 17.1% | 0 (Unchanged) | View |
2022-06-03 5:16 pm Purchase | 13G | RAPT THERAPEUTICS INC RAPT | Redmile Group LLC | 3,199,363 9.9% | 3,199,363 (New Position) | View |
2022-05-09 5:15 pm Purchase | 13G | Deciphera Pharmaceuticals Inc. DCPH | Redmile Group LLC | 5,680,917 8.1% | 5,016,100 (+754.51%) | View |
2022-04-06 5:15 pm Purchase | 13D | MEDAVAIL HLDGS INC MDVLQ | Redmile Group LLC | 32,556,498 41.8% | 21,176,467 (+186.08%) | View |
2022-04-05 5:09 pm Sale | 13D | IGM Biosciences Inc. IGMS | Redmile Group LLC | 3,362,460 12.9% | -75,572 (-2.20%) | View |
2022-02-14 5:07 pm Sale | 13G | Akero Therapeutics Inc. AKRO | Redmile Group LLC | 1,602,285 4.6% | -720,272 (-31.01%) | View |
2022-02-14 5:07 pm Purchase | 13G | AMICUS THERAPEUTICS INC. FOLD | Redmile Group LLC | 28,405,042 9.99% | 6,279,553 (+28.38%) | View |
2022-02-14 5:07 pm Purchase | 13G | Old Ayala Inc ADXS | Redmile Group LLC | 1,472,522 9.9% | 91,445 (+6.62%) | View |
2022-02-14 5:07 pm Sale | 13G | Epizyme Inc. EPZM | Redmile Group LLC | 3,832,475 3.5% | -6,392,930 (-62.52%) | View |
2022-02-14 5:07 pm Purchase | 13G | ImmunoGen Inc. IMGN | Redmile Group LLC | 19,621,981 8.5% | 9,093,802 (+86.38%) | View |
2022-02-14 5:07 pm Purchase | 13G | KRYSTAL BIOTECH INC KRYS | Redmile Group LLC | 1,820,898 7.3% | 145,862 (+8.71%) | View |
2022-02-14 5:07 pm Sale | 13G | LAVA THERAPEUTICS N V SHS LVTX | Redmile Group LLC | 2,816,196 10.9% | -8,213 (-0.29%) | View |
2022-02-14 5:07 pm Purchase | 13G | NEUROGENE INC NGNE | Redmile Group LLC | 4,321,560 9.9% | 125,902 (+3.00%) | View |
2022-02-14 5:07 pm Purchase | 13G | Replimune Group Inc. REPL | Redmile Group LLC | 4,775,461 9.9% | 117,418 (+2.52%) | View |
2022-02-14 5:07 pm Purchase | 13G | Scholar Rock Holding Corp SRRK | Redmile Group LLC | 3,624,880 9.9% | 212,871 (+6.24%) | View |
2022-02-14 5:07 pm Sale | 13G | STEREOTAXIS INC STXS | Redmile Group LLC | 7,308,325 9.1% | -525,440 (-6.71%) | View |
2022-02-14 5:07 pm Sale | 13G | Stoke Therapeutics Inc. STOK | Redmile Group LLC | 2,246,668 6.1% | -439,566 (-16.36%) | View |
2022-02-14 5:07 pm Sale | 13G | KINETA INC. KA | Redmile Group LLC | 62,546 0.6% | -611,003 (-90.71%) | View |
2022-02-14 5:07 pm Sale | 13G | Zentalis Pharmaceuticals Inc. ZNTL | Redmile Group LLC | 0 0% | -2,416,406 (Position Closed) | View |
2022-02-14 5:07 pm Sale | 13G | ALLAKOS INC ALLK | Redmile Group LLC | 2,077,875 3.8% | -589,576 (-22.10%) | View |